Stock 1271 SUNWAY BIOTECH CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials SunWay Biotech Co., LTD.

Equities

1271

TW0001271005

Food Processing

End-of-day quote Taipei Exchange
Other stock markets
 23:00:00 16/05/2024 BST 		5-day change 1st Jan Change
115.5 TWD +0.43% Intraday chart for SunWay Biotech Co., LTD. +0.43% -14.13%
2023 SunWay Biotech Co., LTD. agreed to acquire Bora Health Inc from Bora Pharmaceuticals Co., LTD.. CI
2023 SunWay Biotech Co., LTD. Reports Earnings Results for the Half Year Ended June 30, 2023 CI

Valuation

Fiscal Period: December 2021 2022 2023
Capitalization 1 2,041 1,598 4,568
Enterprise Value (EV) 1 1,697 1,511 4,493
P/E ratio 12.3 x 12 x 91.5 x
Yield 7.06% 6.8% 0.74%
Capitalization / Revenue 5.37 x 4.56 x 8 x
EV / Revenue 4.46 x 4.31 x 7.87 x
EV / EBITDA 9.58 x 9.02 x 70.2 x
EV / FCF 19.8 x 10.3 x -58.8 x
FCF Yield 5.04% 9.72% -1.7%
Price to Book 3.75 x 2.91 x 2.5 x
Nbr of stocks (in thousands) 33,135 33,534 33,960
Reference price 2 61.60 47.65 134.5
Announcement Date 14/04/22 21/04/23 26/04/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 108.7 172.2 314.5 380.4 350.4 571.1
EBITDA 1 -7.043 54.42 136.9 177.1 167.6 64.02
EBIT 1 -20.05 42.09 125.9 167.3 144.4 50.14
Operating Margin -18.46% 24.45% 40.03% 43.97% 41.2% 8.78%
Earnings before Tax (EBT) 1 -11.07 39.59 125.7 170.2 143.5 54.28
Net income 1 -13.53 38.24 125.7 168.8 135.2 44.08
Net margin -12.45% 22.21% 39.98% 44.36% 38.58% 7.72%
EPS 2 -0.4351 1.150 3.940 5.000 3.960 1.470
Free Cash Flow 1 -30.89 59.43 132.9 85.6 146.8 -76.39
FCF margin -28.43% 34.52% 42.26% 22.5% 41.88% -13.38%
FCF Conversion (EBITDA) - 109.21% 97.09% 48.33% 87.59% -
FCF Conversion (Net income) - 155.43% 105.72% 50.72% 108.57% -
Dividend per Share - - 2.798 4.350 3.240 1.000
Announcement Date 30/04/19 29/04/20 16/04/21 14/04/22 21/04/23 26/04/24
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 5.43 - - - - -
Net Cash position 1 - 53.6 293 344 87.1 74.8
Leverage (Debt/EBITDA) -0.7714 x - - - - -
Free Cash Flow 1 -30.9 59.4 133 85.6 147 -76.4
ROE (net income / shareholders' equity) -5.33% 14.7% 33.8% 33.6% 24.7% 2.55%
ROA (Net income/ Total Assets) -4.08% 8.64% 19% 18.7% 11.9% 1.52%
Assets 1 331.9 442.3 662 902.9 1,134 2,907
Book Value Per Share 2 7.720 8.970 14.00 16.40 16.40 53.80
Cash Flow per Share 2 0.5800 2.100 8.950 10.50 11.30 6.100
Capex 1 1.17 0.88 1.56 9.71 1.57 46.2
Capex / Sales 1.07% 0.51% 0.5% 2.55% 0.45% 8.1%
Announcement Date 30/04/19 29/04/20 16/04/21 14/04/22 21/04/23 26/04/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Special Foods & Wellbeing Products

1st Jan change Capi.
SUNWAY BIOTECH CO., LTD. Stock SunWay Biotech Co., LTD.
-14.13% 213M
ZHEJIANG NHU COMPANY LTD. Stock Zhejiang NHU Company Ltd.
+16.86% 8.43B
BELLRING BRANDS, INC. Stock BellRing Brands, Inc.
+3.57% 7.49B
CSPC INNOVATION PHARMACEUTICAL CO., LTD. Stock CSPC Innovation Pharmaceutical Co., Ltd.
+4.89% 6.23B
THE SIMPLY GOOD FOODS COMPANY Stock The Simply Good Foods Company
-5.23% 3.75B
BYHEALTH CO., LTD Stock Byhealth Co., Ltd
-6.58% 3.75B
XIAMEN KINGDOMWAY GROUP COMPANY Stock Xiamen Kingdomway Group Company
-3.55% 1.33B
HERBALIFE LTD. Stock Herbalife Ltd.
-28.64% 1.09B
SIRIO PHARMA CO., LTD. Stock Sirio Pharma Co., Ltd.
+18.12% 1.02B
USANA HEALTH SCIENCES, INC. Stock USANA Health Sciences, Inc.
-8.60% 933M
Special Foods & Wellbeing Products
  1. Stock Market
  2. Equities
  3. 1271 Stock
  4. Financials SunWay Biotech Co., LTD.